Salesforce (CRM): No Urgency to Buy Before Earnings - Wedbush

Wedbush analyst, Steve Koenig, views the current entry point for salesforce.com (NYSE: CRM) shares as compelling on a 12-month basis, due to an outlook for sustained 20%+ growth, attractive trading multiples (28x EV/FCF on CY17E), healthy FCF generation, strong market position and consistent execution. However, the stock has had a nice rally off of its Feb. 8th low and short interest of 1.5% is relatively low so he said their is no particular urgency to buy ahead of earnings.

Salesforce will announce 1Q17/Apr. results AMC on Wednesday, May 18th . The call details are: (866) 901-7332 (passcode: 78127862) at 5:00 pm ET.

The firm maintained an Outperform rating and price target of $95.

For an analyst ratings summary and ratings history on salesforce.com click here. For more ratings news on salesforce.com click here.

Shares of salesforce.com closed at $75.79 yesterday.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Stifel Canada Starts BlackBerry (BB) at Buy
• Alimentation Couche-Tard Inc (ATD/B:CN) (ANCUF) PT Raised to Cdn$104 at UBS